Instrument overview
LKFTLakefront Biotherapeutics
StockNasdaqBelgiumHealth careEU retail: available
+0.8% today · +2.4% over a year
No score: too little data.
Quality: among the best of its peers. No dividend.
Lakefront Biotherapeutics (LKFT) belongs to the Health care sector and is listed on Nasdaq; country: Belgium. Over the past 12 months the price changed by +2.4%, with an annualised volatility of 28% and a largest fall of 25%.
Smart Score
How it is scored →Not scored: not enough data for a fair comparison.
Factor scores
Profitability, balance-sheet safety, growth and capital discipline versus peers. More in the glossary →better than 84% of peers
Price trend over the last 12 and 6 months (excluding the last month) and distance from the 52-week high. More in the glossary →better than 48% of peers
Lower price swings, lower market sensitivity (beta) and shallower drawdowns score higher. More in the glossary →better than 74% of peers
Percentiles within the peer group (100 = the best of its peers); dividend safety in points.
Main drivers
- Accrualsweighs on the score · better than 2% of peers
- Betasupports the score · better than 88% of peers
- Gross profit growth / assets (5 y)supports the score · better than 72% of peers
Red flags and notes
- Caution. Negative free cash flow in at least two of the last three years. More in the glossary → Negative free cash flow in at least two of the last three years.
- Caution. Accruals or the Beneish M-score are in the watch zone. More in the glossary → Accruals or the Beneish M-score are in the watch zone.
Price chart
Interactive chart by TradingView: exchange prices are delayed, crypto and currencies are live.
Key metrics
Profitability and debt
- Return on equity
- 10.5%
- Return on invested capital
- 9.9%
- Gross margin
- 97.3%
Dividends
- Dividend yield
- 0.00%
- Years of dividend growth
- 0
Returns and risk
- 1 day
- +0.8%
- 1 month
- +7.5%
- 1 year
- +2.4%
- Volatility, 1 yr
- 27.6%
- Max drawdown, 1 yr
- −24.7%
- Beta
- 0.63
Ratios from SEC filings and end-of-day prices; returns are price changes without dividends.
Similar companies
Same sector, closest in price swings over the past year.
| ERFEurofins Scientific SE | —/10 | 0.8% | 43.1% |
|---|---|---|---|
| MRKMerck KGaA | —/10 | 1.5% | 31.3% |
| PHGKoninklijke Philips N.V. NY Registry Shares | —/10 | 3.7% | 2.9% |
| SOONSonova Holding AG | —/10 | 1.7% | 29.7% |
| SNSmith & Nephew plc | 6/10 | 2.6% | −18.7% |
| AZNAstraZeneca PLC | 6/10 | 1.3% | 3.7% |
| NVSNovartis AG | 9/10 | 2.5% | 30.3% |
| ALCAlcon | 4/10 | 0.4% | −6.2% |
News and filings
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 20 Oct 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 14 Oct 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 13 Oct 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 9 Oct 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 6 Oct 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 29 Sep 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 22 Sep 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 15 Sep 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 8 Sep 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 8 Sep 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 1 Sep 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 25 Aug 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 25 Aug 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 25 Aug 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 18 Aug 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 12 Aug 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 12 Aug 2026
- Lakefront Biotherapeutics NV: 6-K — Report of a foreign private issuer
A filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.SEC EDGAR · Filing · 4 Aug 2026
What the marks mean
- FactA filing (SEC EDGAR) or an exchange notice (Moscow Exchange): the issuer's or the exchange's own statement.
- Media reportA headline from a named media outlet. We link to it and do not check it.
- RumourUnconfirmed: the headline itself hedges (“reportedly”, “sources say”, “in talks”), names no publisher, or comes from a news aggregator or an automated republisher.
Source: Filings: U.S. SEC EDGAR. The tone is scored automatically from the headline and can be wrong.
Score changes in the last 12 months
Every published rating and change, logged when it was published (EU Market Abuse Regulation).
Show the log: 1 entry
| Date | Event | Balanced | Growth · Income | Warnings | Price at publication |
|---|---|---|---|---|---|
| First rating | —/10 | — · — | Available with Invest Pro |
Ratings are rules-based descriptions, valid until the next scoring run (about 06:20 and 21:50 UTC) and the same for every visitor.
Withdraw from contract here · EU consumers: 14 days to withdraw from a purchase.